GLP-1 drug linked to heart benefits for high-risk patients

Adding the GLP-1 receptor agonist cause tirzepatide (marketed arsenic Mounjaro) to modular attraction for patients with benignant 2 diabetes and bosom illness is associated with a little hazard of a large cardiovascular event, specified arsenic a bosom onslaught oregon stroke, finds a survey published by The BMJ today.